Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;54(3):202-11.
doi: 10.1007/s12275-016-5625-7. Epub 2016 Feb 27.

Innate host defenses against Cryptococcus neoformans

Affiliations
Review

Innate host defenses against Cryptococcus neoformans

Camaron Hole et al. J Microbiol. 2016 Mar.

Abstract

Cryptococcus neoformans, the predominant etiological agent of cryptococcosis, can cause life-threatening infections of the central nervous system in immunocompromised and immunocompetent individuals. Cryptococcal meningoencephalitis is the most common disseminated fungal infection in AIDS patients, and remains the third most common invasive fungal infection among organ transplant recipients. The administration of highly active antiretroviral therapy (HAART) has resulted in a decrease in the number of cases of AIDS-related cryptococcosis in developed countries, but in developing countries where HAART is not readily available, Cryptococcus is still a major concern. Therefore, there is an urgent need for the development of novel therapies and/or vaccines to combat cryptococcosis. Understanding the protective immune responses against Cryptococcus is critical for development of vaccines and immunotherapies to combat cryptococcosis. Consequently, this review focuses on our current knowledge of protective immune responses to C. neoformans, with an emphasis on innate immune responses.

Keywords: Cryptococcus; Cryptococcus neoformans; fungal immunity; fungal pathogenesis; host-fungal interactions.

PubMed Disclaimer

References

    1. Semin Immunol. 2014 Aug;26(4):329-40 - PubMed
    1. J Immunol. 2012 Oct 15;189(8):4060-8 - PubMed
    1. Infect Immun. 2005 Feb;73(2):820-7 - PubMed
    1. Am J Pathol. 2009 Mar;174(3):932-43 - PubMed
    1. J Clin Invest. 2010 Apr;120(4):1355-61 - PubMed

Substances

LinkOut - more resources